Pro-ACR: Search for Prognostic Factors Associated With Better Survival in Refractory Cardiac Arrest

Sponsor

Centre Hospitalier Universitaire Dijon (Other)

Overall Status

Unknown status

CT.gov ID

NCT03261232

Collaborator

(none)

Enrollment

Location

Anticipated Duration (Months)

2.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Through this retrospective observational study (over 4 years; period analysed: 1st January 2011 to 31st December 2014), we looked for prognostic factors associated with better survival in refractory cardiac arrest by:

assessing the overall survival rate
evaluating the frequency of intra et extra-hospital events and by comparing these with the survival rate
studying no flow, low flow, rhythm at initial management, troponinemia, lactatemia and blood pH in the different groups.

Condition or Disease	Intervention/Treatment	Phase
Cardiac Arrest (CA) ExtraCorporeal Life Support (ECLS)

Study Design

Study Type:

Observational

Anticipated Enrollment :

65 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Prognostic Factors in Refractory Cardiac Arrest Treated With Extracorporeal Life Support at Dijon CHU

Actual Study Start Date :

Mar 1, 2016

Anticipated Primary Completion Date :

Mar 1, 2018

Anticipated Study Completion Date :

Mar 1, 2018

Outcome Measures

Primary Outcome Measures

Survival rate [at baseline]
Death rate [at baseline]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 75 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patients with in-hospital or out-of-hospital refractory CA who underwent ECLS

Exclusion Criteria:

CA occurring during cardiac surgery
Age > 75 years or < 18 years

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHU Dijon Bourgogne	Dijon		France	21079

Sponsors and Collaborators

Centre Hospitalier Universitaire Dijon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Centre Hospitalier Universitaire Dijon

ClinicalTrials.gov Identifier:

NCT03261232

Other Study ID Numbers:

ELLOUZE 2016 Pro-ACR

First Posted:

Aug 24, 2017

Last Update Posted:

Aug 24, 2017

Last Verified:

Aug 1, 2017

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Heart Arrest

Study Results

No Results Posted as of Aug 24, 2017